We confirmed that STZ injection induced type 1 diabetic features such as hyperglycemia, loss of body weight, decrease in insulin level, increase in HbA1c level, and glucose intolerance, as previously reported [37]. The gene discussed is INS; the disease is Glucose intolerance.